Brian M. Stolz
2013
In 2013, Brian M. Stolz earned a total compensation of $1.2M as Senior Vice President and General Manager at Valeant Pharmaceuticals International.
Compensation breakdown
| Non-Equity Incentive Plan | $707,813 |
|---|---|
| Salary | $468,750 |
| Other | $9,876 |
| Total | $1,186,439 |
Stolz received $707.8K in non-equity incentive plan, accounting for 60% of the total pay in 2013.
Stolz also received $468.8K in salary and $9.9K in other compensation.
Rankings
In 2013, Brian M. Stolz's compensation ranked 5,884th out of 12,286 executives tracked by ExecPay. In other words, Stolz earned more than 52.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,884 out of 12,286 | 52nd |
Division Manufacturing | 2,039 out of 4,614 | 56th |
Major group Chemicals And Allied Products | 598 out of 1,466 | 59th |
Industry group Drugs | 428 out of 1,160 | 63rd |
Industry Pharmaceutical Preparations | 343 out of 890 | 62nd |
Source: SEC filing on April 29, 2016.
Stolz's colleagues
We found seven more compensation records of executives who worked with Brian M. Stolz at Valeant Pharmaceuticals International in 2013.
2013
Robert Chai-Onn
Valeant Pharmaceuticals International
Chief Legal Officer
2013
Laizer Kornwasser
Valeant Pharmaceuticals International
Group Chairman
2013
Daniel Wechsler
Valeant Pharmaceuticals International
Group Chairman
2013
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2013
Howard Schiller
Valeant Pharmaceuticals International
Chief Financial Officer
2013
Debora Jorn
Valeant Pharmaceuticals International
Group Chairman
2013
Pavel Mirovsky
Valeant Pharmaceuticals International